Faheem Hasnain is EVP & Oncology/Rheumatology SBU at BIOGEN IDEC INC. (BIIB). They have made 16 open-market trades across 5 companies since 2006, most recently 2026-01-02.
CIK 0001352620
11 open-market purchases totalling $10.5M since 2016, against 5 sales. Across 11 scored buys the stock is up 1.6% at ninety days, and 2.1 points behind the S&P over the same stretch.
11 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 45% | 55% | 55% |
| Avg Move | +1.4% | +6.3% | +1.6% |
| Alpha | +0.6% | +3.9% | -2.1% |
| Scored | 11 | 11 | 11 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KURA | SELL | 2025-12-09 | 2025-12-10 | $10.98 | $110K | +5.3% | -12.1% | -13.5% |
| KURA | SELL | 2025-03-21 | 2025-03-24 | $8.00 | $181K | -19.5% | -16.8% | -23.4% |
| GOSS | BUY | 2024-06-21 | 2024-06-24 | $0.67 | $498K | +17.4% | +16.3% | +8.7% |
| GOSS | SELL | 2024-03-27 | 2024-03-28 | $1.16 | $27K | -15.3% | -41.0% | -20.4% |
| MRTX | BUY | 2023-08-11 | 2023-08-14 | $27.80 | $600K | -12.9% | -15.8% | +39.2% |
| GOSS | BUY | 2023-03-20 | 2023-03-22 | $1.14 | $2.0M | -12.5% | -5.5% | +2.7% |
| GOSS | BUY | 2022-07-15 | 2022-07-15 | $7.21 | $2.0M | +3.0% | +23.2% | +5.3% |
| GOSS | SELL | 2022-03-23 | 2022-03-24 | $8.92 | $340K | -1.6% | +2.1% | -18.2% |
| GOSS | BUY | 2020-10-14 | 2020-10-14 | $10.36 | $2.0M | -3.9% | -6.5% | +8.0% |
| GOSS | BUY | 2019-09-27 | 2019-09-27 | $16.80 | $168K | -9.1% | +12.8% | -5.4% |
| TOCA | BUY | 2019-05-30 | 2019-06-03 | $4.63 | $379K | +22.4% | +20.3% | -32.7% |
| VTL | SELL | 2018-09-13 | 2018-09-17 | $0.44 | $130K | +7.2% | +19.1% | -16.3% |
| VTL | BUY | 2017-09-14 | 2017-09-15 | $4.19 | $496K | +2.1% | +19.1% | +17.0% |
| TOCA | BUY | 2017-04-19 | 2017-04-21 | $10.00 | $1.0M | +23.8% | +21.9% | -23.4% |
| VTL | BUY | 2016-08-12 | 2016-08-15 | $5.92 | $700K | -7.5% | -8.1% | -0.8% |
| VTL | BUY | 2016-08-12 | 2016-08-15 | $5.92 | $700K | -7.5% | -8.1% | -0.8% |
| RCPT | SELL · 10b5-1 | 2014-11-10 | 2014-11-12 | $109.47 | $21.9M | N/A | N/A | N/A |
| BIIB | SELL · 10b5-1 | 2008-07-09 | 2008-07-10 | $62.07 | $2.3M | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2008-04-08 | 2008-04-10 | $64.47 | $414K | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2007-05-23 | 2007-05-24 | $49.00 | $365K | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2006-10-02 | 2006-10-03 | $44.63 | $502K | -11.0% | -1.9% | -1.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| NUVB |
| 25,000 |
| $111K |
| RCPT | 32,500 | — |
| SOMX | 24,454 | — |
| FACT | 102,667 | — |
| Total | $29.5M |
Shares reported on the most recent Form 4, priced at the 2026-01-05 close. 3 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.